Pomerantz Roger

CIK 00016149366 companiesCHALFONT, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001614936

Recent Transactions

50 trades

Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-06-10+30,000→ 30,000 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.50/sh−500→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.50/sh−250→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.50/sh−250→ 0 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2024-11-25−9,034→ 18,069 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-11-25+9,034→ 126,478 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2024-08-25−9,034→ 27,103 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-08-25+9,034→ 117,444 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2024-06-20+18,750→ 18,750 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2024-06-20+50,000→ 50,000 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2024-06-06+30,000→ 30,000 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2024-05-25−9,035→ 36,137 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-05-25+9,035→ 108,410 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2024-02-25−9,034→ 45,172 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2024-02-25+9,034→ 99,375 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-11-25+9,034→ 90,341 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-11-25−9,034→ 54,206 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-08-25+9,034→ 81,307 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-08-25−9,034→ 63,240 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2023-08-16+15,000→ 15,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2023-06-08+40,000→ 40,000 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2023-05-25+30,000→ 30,000 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-05-25−9,035→ 72,274 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-05-25+9,035→ 72,273 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-02-25−9,034→ 81,309 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-02-25+9,034→ 63,238 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-11-25−9,034→ 90,343 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-11-25+9,034→ 54,204 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2022-09-30+81,000→ 81,000 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-08-25+9,034→ 45,170 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-08-25−9,034→ 99,377 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2022-08-10+30,282→ 30,282 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2022-06-09+40,000→ 40,000 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-05-25+9,034→ 36,136 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-05-25−9,034→ 108,411 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-02-25+9,034→ 27,102 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-02-25−9,034→ 117,445 total
Award
CONTRAFECT Corp
Options (Right to Buy)
2022-02-15$3.33/sh+500,000→ 500,000 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-25+18,068→ 18,068 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2021-11-25−18,068→ 126,479 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2021-08-04+41,000→ 41,000 total
Award
CONTRAFECT Corp
Options (Right to Buy)
2021-04-08+254,000→ 254,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-03-26+135,000→ 135,000 total
Award
Intec Pharma Ltd.
Stock Option (right to buy)
2020-07-15+40,000→ 40,000 total
Award
Intec Pharma Ltd.
Stock Option (right to buy)
2019-06-28+20,000→ 20,000 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2019-06-13+15,000→ 15,000 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2018-09-07$9.00/sh−1,810→ 213,976 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2018-09-06$9.04/sh−3,013→ 215,786 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2018-09-05$9.12/sh−9,505→ 218,799 total
Purchase
Rubius Therapeutics, Inc.
Common Stock
2018-07-20$23.00/sh+100→ 100 total

Companies

Recent Filings

Address

711 HARVEST HILL ROAD

CHALFONT, PA, 18914

View on SEC.gov